Exploring the brain-body composition relationship in Huntington's disease.

Area of Science:

• Neuroscience
• Genetics
• Metabolic Medicine

Background:

• Huntington's disease (HD) is a neurodegenerative disorder characterized by progressive motor, cognitive, and psychiatric decline.
• Changes in body composition are frequently observed in HD patients and correlate with disease progression.
• The relationship between body composition and early neurodegeneration, specifically in the striatum, remains unclear in premanifest HD.

Purpose of the Study:

• To investigate the association between body composition metrics and striatal brain volume.
• To compare body composition and striatal volume in individuals with premanifest HD and healthy controls.
• To identify potential early biomarkers of neurodegeneration in Huntington's disease.

Main Methods:

• Cross-sectional study design involving 21 individuals with premanifest HD and 22 healthy controls.
• Body composition analysis using dual-energy X-ray absorptiometry (DXA).
• Assessment of striatal volume via structural magnetic resonance imaging (MRI).

Main Results:

• No significant differences in overall body composition were found between premanifest HD and control groups.
• A significant reduction in striatal volume was observed in individuals with premanifest HD compared to controls.
• A notable association was identified between bone mineral density (BMD) and the volume of the right putamen in the premanifest HD group.

Conclusions:

• Striatal degeneration is detectable in the premanifest stages of Huntington's disease.
• Bone mineral density may be an early indicator associated with striatal changes in premanifest HD.
• Further longitudinal research is warranted to confirm these preliminary findings and explore causal relationships.